206 related articles for article (PubMed ID: 26547102)
1. Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses.
Zenda S; Akimoto T; Mizumoto M; Hayashi R; Arahira S; Okumura T; Sakurai H
Radiother Oncol; 2016 Feb; 118(2):267-71. PubMed ID: 26547102
[TBL] [Abstract][Full Text] [Related]
2. Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study.
Zenda S; Kawashima M; Nishio T; Kohno R; Nihei K; Onozawa M; Arahira S; Ogino T
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):135-9. PubMed ID: 20950948
[TBL] [Abstract][Full Text] [Related]
3. [The epidemiology and clinical characteristics of malignant melanoma localized in nasal cavity and paranasal sinuses--analysis of 6 cases].
Ziółkowska M; Bień S; Klimas A; Zyłka S
Otolaryngol Pol; 2008; 62(4):500-3. PubMed ID: 18837235
[TBL] [Abstract][Full Text] [Related]
4. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses.
Zenda S; Kohno R; Kawashima M; Arahira S; Nishio T; Tahara M; Hayashi R; Kishimoto S; Ogino T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1473-8. PubMed ID: 20961697
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy for mucosal melanoma of the head and neck.
Christopherson K; Malyapa RS; Werning JW; Morris CG; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2015 Feb; 38(1):87-9. PubMed ID: 23563215
[TBL] [Abstract][Full Text] [Related]
6. Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses.
Combs SE; Konkel S; Thilmann C; Debus J; Schulz-Ertner D
Strahlenther Onkol; 2007 Feb; 183(2):63-8. PubMed ID: 17294109
[TBL] [Abstract][Full Text] [Related]
7. Failure patterns and prognostic factors of patients with primary mucosal melanoma of the nasal cavity and paranasal sinuses.
Liu ZP; Luo JW; Xu GZ; Gao L; Yi JL; Huang XD; Qu Y; Wang K; Zhang SP; Xiao JP
Acta Otolaryngol; 2017 Oct; 137(10):1115-1120. PubMed ID: 28767022
[TBL] [Abstract][Full Text] [Related]
8. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses.
Gilligan D; Slevin NJ
Br J Radiol; 1991 Dec; 64(768):1147-50. PubMed ID: 1773274
[TBL] [Abstract][Full Text] [Related]
9. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.
Fukumitsu N; Okumura T; Mizumoto M; Oshiro Y; Hashimoto T; Kanemoto A; Hashii H; Ohkawa A; Moritake T; Tsuboi K; Tabuchi K; Wada T; Hara A; Sakurai H
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):704-11. PubMed ID: 22099036
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of primary nasal mucosal melanoma--a report of 44 cases].
Peng RQ; Wu GH; Chen WK; Ding Y; Ma J; Zhang NH; Su YS; Zhang XS
Ai Zheng; 2006 Oct; 25(10):1284-6. PubMed ID: 17059777
[TBL] [Abstract][Full Text] [Related]
12. Single-center retrospective series of fourteen patients with mucosal melanoma of the nasal cavity and paranasal sinuses.
Letievant JC; Poupart M; Ambrun A; Colin C; Pignat JC
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):387-391. PubMed ID: 27502822
[TBL] [Abstract][Full Text] [Related]
13. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.
Zenda S; Kawashima M; Arahira S; Kohno R; Nishio T; Tahara M; Hayashi R; Akimoto T
Int J Clin Oncol; 2015 Jun; 20(3):447-54. PubMed ID: 25135461
[TBL] [Abstract][Full Text] [Related]
14. Malignancies of the nasal cavity and paranasal sinuses: long-term outcome with conventional or three-dimensional conformal radiotherapy.
Dirix P; Nuyts S; Geussens Y; Jorissen M; Vander Poorten V; Fossion E; Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1042-50. PubMed ID: 17570610
[TBL] [Abstract][Full Text] [Related]
15. Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.
Kadah BA; Niewald M; Papaspyrou G; Dzierma Y; Schneider M; Schick B
Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1543-7. PubMed ID: 25905695
[TBL] [Abstract][Full Text] [Related]
16. Mucosal melanoma of nasal cavity and paranasal sinus.
Dwivedi R; Dwivedi R; Kazi R; Kumar S; Agarwal SP
J Cancer Res Ther; 2008; 4(4):200-2. PubMed ID: 19052396
[TBL] [Abstract][Full Text] [Related]
17. Head and neck mucosal melanoma.
Mendenhall WM; Amdur RJ; Hinerman RW; Werning JW; Villaret DB; Mendenhall NP
Am J Clin Oncol; 2005 Dec; 28(6):626-30. PubMed ID: 16317276
[TBL] [Abstract][Full Text] [Related]
18. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.
Dirix P; Nuyts S; Vanstraelen B; Nulens A; Hermans R; Jorissen M; Vander Poorten V; Van den Bogaert W
Radiother Oncol; 2007 Dec; 85(3):385-91. PubMed ID: 17963908
[TBL] [Abstract][Full Text] [Related]
19. [Plasmocytoma in the nasal cavity and paranasal sinuses].
Bień S; Kobiorska-Nowak J
Otolaryngol Pol; 2009; 63(3):287-92. PubMed ID: 19886539
[TBL] [Abstract][Full Text] [Related]
20. Dose distribution resulting from changes in aeration of nasal cavity or paranasal sinus cancer in the proton therapy.
Fukumitsu N; Ishikawa H; Ohnishi K; Terunuma T; Mizumoto M; Numajiri H; Aihara T; Okumura T; Tsuboi K; Sakae T; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):72-6. PubMed ID: 25245554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
